ArticleEClinicalMedicine2024

Safety and durability of mRNA-1273-induced SARS-CoV-2 immune responses in adolescents: results from the phase 2/3 TeenCOVE trial.

Amparo L Figueroa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.